June 1, 2018
Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from early interventions, or might be at risk of an impending flare. These findings are published in the open-access journal Molecular Medicine.
